Cowan Chad, Chief Scientific Officer at Century Therapeutics ($IPSC), made one open market purchase of company shares worth about $49,252 in the last year, with the most recent on December 22, 2025. This ranks him 3,060th among nearly 5,000 insiders, well below the average purchase of 1.5 million across 3.3 transactions. He also sold shares once for about $2,736, most recently on November 20, 2025, ranking 11,468th out of nearly 12,000 insiders versus an average sale of 8.6 million over 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | Century Therapeutics, Inc. | $IPSC | Cowan Chad | Chief Scientific Officer | F | Common Stock | 1431 | $2.73 | 1,187,742.0000 | 86,464,066 | 0.12% | 0.00% |
| Feb. 2, 2026 | Century Therapeutics, Inc. | $IPSC | Cowan Chad | Chief Scientific Officer | A | Stock Option (right to buy) | 265000 | $0.00 | 265,000.0000 | 86,464,066 | 9999.99% | 0.31% |
| Feb. 2, 2026 | Century Therapeutics, Inc. | $IPSC | Cowan Chad | Chief Scientific Officer | A | Common Stock | 135000 | $0.00 | 1,189,173.0000 | 86,464,066 | 12.81% | 0.16% |
| Jan. 2, 2026 | Century Therapeutics, Inc. | $IPSC | Cowan Chad | Chief Scientific Officer | F | Common Stock | 1611 | $1.00 | 1,054,173.0000 | 86,464,066 | 0.15% | 0.00% |
| Dec. 22, 2025 | Century Therapeutics, Inc. | $IPSC | Cowan Chad | Chief Scientific Officer | P | Common Stock | 58060 | $0.85 | 1,055,784.0000 | 86,464,066 | 5.82% | 0.07% |
| Nov. 20, 2025 | Century Therapeutics, Inc. | $IPSC | Cowan Chad | Chief Scientific Officer | S | Common Stock | 5462 | $0.50 | 997,724.0000 | 86,464,066 | 0.54% | 0.01% |
| Sept. 18, 2025 | Century Therapeutics, Inc. | $IPSC | Cowan Chad | Chief Scientific Officer | A | Common Stock | 762543 | $0.00 | 1,003,186.0000 | 86,238,084 | 316.88% | 0.88% |
| March 11, 2025 | Century Therapeutics, Inc. | $IPSC | Cowan Chad | Chief Scientific Officer | A | Common Stock | 19500 | $0.00 | 241,003.0000 | 78,648,958 | 8.80% | 0.02% |
| March 11, 2025 | Century Therapeutics, Inc. | $IPSC | Cowan Chad | Chief Scientific Officer | A | Stock Option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,648,958 | 9999.99% | 0.02% |
| Oct. 1, 2024 | Century Therapeutics, Inc. | $IPSC | Cowan Chad | Chief Scientific Officer | A | Stock Option (right to buy) | 446250 | $0.00 | 446,250.0000 | 84,704,352 | 9999.99% | 0.53% |
| Oct. 1, 2024 | Century Therapeutics, Inc. | $IPSC | Cowan Chad | Chief Scientific Officer | A | Common Stock | 74376 | $0.00 | 221,503.0000 | 84,704,352 | 50.55% | 0.09% |